$33.99
0.00 (0%)
ICOS CP (ICOS.DL)
CAPS Rating:
A biotechnology company, which through Lilly ICOS LLC, markets Cialis (tadalafil) for the treatment of erectile dysfunction. Works to develop potential treatments for other serious unmet medical conditions such as cancer and inflammatory diseases.
No one has written a Pitch for ICOS.DL stock yet. Tell us why you think ICOS.DL will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
